BioSpace News Archive

Innovus Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has cleared the Company’s GlucoGorx™ Glucose Monitoring Test Kit that includes a glucose meter, test strips and lancet device (“GlucoGorx™ Kit”) under the 510(k) filing of its manufacturing partner, ACON Laboratories, Inc. (“ACON”) Innovus Pharma will offer the GlucoGorx™ Kit.

Caris Life Sciences® announced that the University of South Alabama Mitchell Cancer Institute (MCI) has joined Caris’ Precision Oncology Alliance™ (POA).

BiondVax Pharmaceuticals Ltd. reported today it will present at the Universal Influenza Vaccines 2018 Conference.

Prometic Life Sciences Inc. announced positive clinical activity observed in Alström syndrome (AS) patients treated with PBI-4050 in the ongoing Phase 2 open label clinical trial being conducted in the UK.

Femtogenix, Ltd announced it will present data highlighting the high potency of its new generation of DNA binders for ADCs at the American Association for Cancer Research (AACR) Annual Meeting 2018.

MAXIMUS announced that the MAXIMUS Center for Health Literacy has been recognized by the Center for Plain Language with the ClearMark Award of Distinction for achievements on two state projects.

CollPlant announced the appointment of Revital Mandil-Levin, PhD, MBA as Chief Business Development Officer, effective immediately.

NGDATA® announced details of its upcoming webinar, “Start Your Data Lake Right: Leveraging AWS and Informatica to Drive Engagement,” taking place Thursday, April 12th at 11:00 am EDT.

Mr. Laranjo will direct future marketing activities associated with Roclatan, a fixed dose combination of Aerie product Rhopressa®, and widely prescribed PGA latanoprost

The meeting is taking place April 14-18, 2018 in Chicago.